Sphera Funds Management Ltd. Cyma Bay Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $2.82 Million - $4.64 Million	345,535 New	345,535 $4.59 Million
Q1 2018 May 10, 2018	SELL	$9.0 - $15.16 $2.16 Million - $3.64 Million	-240,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$7.67 - $9.31 $1.84 Million - $2.23 Million	240,000	240,000 $2.21 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.